Topic Statement: Glenmark Pharma, despite a minor correction, remains on a bullish trajectory with strong support levels.
Key Points: 1. A head and shoulders pattern led to a price breakdown and a brief correction. 2. The stock found support at the uptrend line, maintaining its bullish structure. 3. The price is at the 38.2% retracement level, a key support area previously held in July and August 2024.
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.